- Tytuł:
- Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer.
- Autorzy:
- Źródło:
- Therapeutic Advances in Medical Oncology; 12/25/2023, p1-18, 18p
Czasopismo naukowe